Elevance Health, Inc. (FRA:A58)
Germany
· Delayed Price · Currency is EUR 324.30
-1.10 (-0.34%)
Last updated: Jun 23, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Other Revenue seg1 | -30.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg1 Growth | 19.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial & Specialty Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial & Specialty Business Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Government Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Government Business Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
CarelonRx | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
CarelonRx Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other | 347.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Growth | -32.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Commercial & Specialty Business Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercial & Specialty Business Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Government Business Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Government Business Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBIT seg1 | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBIT seg1 Growth | -117.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
CarelonRx Operating Income | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
CarelonRx Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Health Benefits Operating Income | 6.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Health Benefits Operating Income Growth | -12.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Operating Income | -1.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate & Other Operating Income Growth | 24.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Total Medical Membership | 45.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Medical Membership Growth | -0.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|